Authors
Latest:
When it comes to urology teaching or learning opportunities, just say yes"Despite the uncertain times, I am grateful to be a student in the field of medicine, where compassion is one of the traits that defines its practitioners," says PA student Steffanie Robertus.
Latest:
Comparing Leuprolide Formulations in Advanced Prostate CancerIn the third article of the series, Melanie McGilloway, NP-C, an advanced practice provider at Genesis Urology in San Diego, discusses the various formulations of leuprolide, a gonadotropin-releasing hormone (GnRH) agonist used for treating advanced prostate cancer.
Latest:
Management of BCG-unresponsive NMIBC"An alternative off-label option for patients with BCG-unresponsive NMIBC is sequential intravesical gemcitabine and docetaxel (Gem/Doce)," write Rachel Passarelli, MD, and Vignesh T. Packiam, MD.
Latest:
Legislation improves accessibility to mental health programs for cliniciansCongress has taken actions aimed at protecting arrangements in which hospitals and other entities provide bona fide mental health improvement, behavioral health improvement, or maintenance programs to physicians and other clinicians.
Latest:
Radium-223 is associated with low rates of AEs, treatment discontinuation for bone metastatic CRPCOf note, 55% of patients received a full course (6 injections) of radium-223 injections, and 67% received 5 of the 6 injections.
Latest:
Mayo study finds dietary habits that may help prevent kidney stones"Knowing the dietary factors that are most important for preventing kidney stone recurrence can help patients and providers know what to prioritize,” said Andrew Rule, MD.
Latest:
Management of recurrent prostate cancer after focal therapyProviders must carefully consider treatment options to align with patient preference.
Latest:
Survey highlights communication gaps with kidney cancer diagnosis and care“This indicates opportunities to improve communication about diagnosis, psychosocial impacts, and clinical trials, as well as biopsies, physical exercise, and patient engagement,” wrote Rachel H. Giles, PhD, and colleagues.
Latest:
Optimizing Patient Selection and Treatment Sequencing in BCG-Unresponsive NMIBCNeal Shore, MD, FACS, offers clinical insights on optimizing patient selection and treatment sequencing in BCG-unresponsive NMIBC.
Latest:
Financial toxicity is a growing concern in urologic oncology"Clinicians have opportunities to reduce patient subjective and objective financial burden if they continue to self-educate and communicate with patients and consider [financial toxicitiy] an adverse effect of treatment," write Alexandria A. Spellman, MD, MS, and Deborah R. Kaye, MD, MS.
Latest:
The Future of Prostate Cancer ImagingProstate cancer experts highlight some closing thoughts and exciting research in progress on prostate cancer imaging.
Latest:
13 tips to keep your patient data safe from hackersHere are 13 cybersecurity measures medical practices can take to protect patient data from hackers.
Latest:
PARP inhibitors: Treating mCRPC from a genetic basisTreatments provide a targeted therapeutic strategy for metastatic castration-resistant prostate cancer.
Latest:
Practice Management: Expert coding tipsA physician’s goal is to care for patients, but a key part of being able to provide that care is the eternal quest for payment.
Latest:
Upper tract urothelial carcinoma case illustrates rapidly changing treatment landscapeUrologists and medical oncologists should collaborate to tailor therapy to the specific needs of the patient.
Latest:
Management of recurrent prostate cancer after focal therapyProviders must carefully consider treatment options to align with patient preference.
Latest:
Strategies to enable same-day robotic urologic surgerySetting expectations and minimizing ports and drains are among steps to take.
Latest:
Fertility preservation in patients with testicular cancer"Full discussion of the various fertility preservation options and an understanding of the fertility implications of the various treatment modalities must be understood by patients for them to make optimal decisions for their reproductive futures," write the authors.
Latest:
Urology Practice advice: Real estate pitfalls to avoidCommercial real estate can be one of the highest expenses for health care practices.
Latest:
Exciting Prospects for the Future of Localized Prostate Cancer TreatmentDr Mark Emberton shares what developments are visible on the horizon and what they represent for the future of focal therapy and treatment of clinically localized prostate cancer.
Latest:
Unmet Needs for the Treatment of Enteric HyperoxaluriaDr. Kyle Wood discusses optimal avenues to increase patient and provider education on enteric hyperoxaluria and provides closing thoughts on the future management of enteric hyperoxaluria.
Latest:
A Look Into The Future of PSMA-Targeted Therapies in Prostate CancerPanelists review the recent FDA approval of the PSMA-targeted therapy Lutetium Lu 177 vipivotide tetraxetan for patients with metastatic castration-resistant prostate cancer and discuss additional settings in which it, and other PSMA-targeted treatments, might be used in the future.
Latest:
Future Landscape of Prostate Cancer and Rectal SpacersThe expert panel concludes their discussion with a look toward the future of prostate cancer treatment and the evolving role of rectal spacers.
Latest:
BCG-unresponsive NMIBC: Current evidence and optionsMultiple investigational agents have been developed and are being studied.
Latest:
Future of Overactive Bladder TreatmentDrs MacDiarmid and Rogers discuss barriers to OAB treatments and therapies on the horizon.
Latest:
A primer on DNA sequencing for the practicing urologistEmbracing and understanding new and emerging molecular techniques will improve patient outcomes.
Latest:
Reining in the administrative burden in health careDoctors and medical practices are mired in administrative tasks.
Latest:
Potential code for prior authorizations on AMA CPT Editorial Panel meeting agenda"Good public and economic policy must align costs, benefits, and incentives; currently, all costs are incurred by physician practices, and all financial savings and benefits from prior authorization accrue to health insurance plans, leading to perverse incentives,” says Alex Shteynshlyuger, MD.
Latest:
Investigators identify new target for VTE prevention"This study identifies a new target for VTE prevention," writes Kate Gessner, MD, PhD, and Philip Abbosh, MD, PhD.
Latest:
Urologist's Perspective: COVID-19 provides tough decisions—and valuable lessonsUrologists and patients show resilience, but we must be better prepared in the future, says urologist R. Jonathan Henderson, MD.
